Company Information
USD
17.24
- (0.5%)
NASDAQ:YMAB, Y-MABS THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 6 May 2024 GMT-4
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
Address
230 Park Avenue
Suite 3350
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Mary A. Tagliaferri, M.D.
Director
Mr. David N. Gill
Director
Mr. Johan Wedell-Wedellsborg
Director
Dr. James I. Healy, M.D.,PhD
Chairman of the Board/Director
Ms. Laura J. Hamill
Director
Mr. Bo Kruse
CFO/Chief Accounting Officer/Executive VP/Secretary/Treasurer
Mr. Thomas Gad
Director/Founder/Other Executive Officer/Vice Chairman of the Board
Dr. Ashutosh Tyagi, M.D.
Director
Dr. Gerard Ber, PhD
Director
Mr. Michael Rossi
CEO/Director/President
Dr. Steen Lisby
Chief Scientific Officer/Senior VP
Dr. Torben Lund-Hansen, PhD
Chief Technology Officer/Senior VP
Mr. Joris Wiel Jan Wilms
COO/Senior VP
Mr. Vignesh Rajah
Chief Medical Officer/Senior VP
Ms. Sue Smith
Other Executive Officer/Senior VP
Ownership
Institution Holdings
HBM Partners Cayman Ltd
3,297,800 (7.533%)
BlackRock Inc
2,917,080 (6.663%)
Vanguard Group Inc
2,244,238 (5.127%)
Sofinnova Ventures
2,194,278 (5.012%)
Polar Capital Holdings PLC
2,056,872 (4.699%)
Polar Capital LLP
1,737,440 (3.969%)
BlackRock Fund Advisors
1,675,240 (3.827%)
D. E. Shaw & Co LP
1,349,210 (3.082%)
Vanguard Investments Australia Ltd
1,159,178 (2.648%)
Caligan Partners LP
1,048,425 (2.395%)
Individual Holdings
Mr. Bo Kruse
210,877 (0.483%)
Mr. Mahiuddin Ahmed
150,000 (0.377%)
Mr. Thomas Gad
162,600 (0.373%)
Mr. Michael Rossi
35,700 (0.082%)
Dr. Steen Lisby
35,600 (0.082%)
Dr. Torben Lund-Hansen, PhD
35,600 (0.082%)
Mr. Joris Wiel Jan Wilms
35,600 (0.082%)
Mr. Vignesh Rajah
35,600 (0.082%)
Dr. James I. Healy, M.D.,PhD
28,108 (0.064%)
Mr. David N. Gill
2,330 (0.005%)
Funds Holdings
iShares Russell 2000 ETF
919,124 (2.100%)
Vanguard Institutional Extnd Mkt Idx Tr
460,250 (1.051%)
Fidelity Small Cap Index Fund
369,735 (0.845%)
iShares Biotechnology ETF
257,926 (0.589%)
iShares Russell 2000 Value ETF
178,048 (0.407%)
Fidelity Extended Market Index Fund
163,102 (0.373%)
iShares Russell 2000 Growth ETF
156,054 (0.356%)
Vanguard Russell 2000 Index Fund
124,458 (0.284%)
Vanguard Health Care Index Fund
118,542 (0.271%)
NT R2000 Index Fund - NL
101,551 (0.232%)
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
